Company intelligence / Profile preview

Aspire Pharma

Godalming, Surrey, UKaspire-pharma.com ↗

Ownership: Private
Development stage: Commercial

Overview

Aspire Pharma is an active UK-based pharmaceutical company focused on the development, licensing, and commercialization of generic and branded drugs as well as medical devices. It supplies a broad portfolio across multiple therapeutic areas to the NHS and international markets. The company's business model emphasizes enhancing existing molecules or devices for improved patient outcomes. Clinical results are not typically published for generics companies; their products are generally approved based on bioequivalence or established safety/efficacy.

Therapeutic areas: Men's HealthOncologyPulmonologyDermatologyGastroenterologyOphthalmologyNeurologyInfectious Diseases
Modalities: Small moleculeMedical device
Industry: Biotech

Partnerships

NHSglobal aid organizationswholesalers/pharmacy groups

Beyond the preview

Go deeper on Aspire Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aspire Pharma.

Explore the full profile